“Psychedelics, specifically psilocybin, have shown promise in treating various psychological symptoms including anxiety, depression, post-traumatic stress disorder, and end-of-life distress,” they wrote.
July 21, 2023
The Ohio Medical Cannabis Board approved IBS as a qualifying condition to use medical marijuana while rejecting petitions to add OCD and autism.
July 18, 2023
But will psychedelic researchers view the FDA guidelines in a positive light?
June 27, 2023
Researchers examined the effects on male mice.
June 15, 2023
Minnesota state officials announced on Wednesday that the health department will add IBS and OCD to the list of qualifying medical conditions for participation in the state’s medical cannabis program.
December 1, 2022